Image For Activity Cover
Hybrid Therapies for AF: Present and Future
Learning Objectives
  • Recognize unmet treatment need in patients with advanced atrial fibrillation
  • Recognize the importance of non-pulmonary vein triggers
  • Understand left atrial appendage as a therapeutic target
  • Undertand the evolution of Hybrid Convergent Therapy
  • Discuss the future of hybrid approaches
Target Audience
This activity is designed for all health care providers who manage atrial fibrillation patients and conduct research in this area. 
Faculty List

Moderators:

Hugh Calkins, MD, FHRS, CCDS
Johns Hopkins Hospital 


Andrea Russo, MD, FHRS
Cooper University Hospital 


Speakers:

David DeLurgio, MD, FHRS
Emory St. Joseph's Hospital

Andy Kiser, MBA, MD
St. Clair Cardiovascular Surgery Associates 


Dhanunjaya Lakkireddy, MD, FHRS
The Kansas City Heart Rhythm Institute at HCA Midwest Health


Dave Wilber, MD, FHRS
The Kansas City Heart Rhythm Institute at HCA Midwest Health


Luigi Di Biasi, MD, PhD, FHRS
Albert Einstein College of Medicine


Suneet Mittal, BA, MD, FHRS
The Valley Hospital
CME Statements

Accreditation Statement
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians AMA Designation Statement
The Heart Rhythm Society designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Grant Acknowledgement

The Heart Rhythm Society gratefully acknowledges AtriCure, Inc.for their support of this program.

Disclosure Policy

CME Disclosure Policy

The Heart Rhythm Society is committed to the provision of Continuing Medical Education (CME) that is balanced, objective, and evidence-based. The Heart Rhythm Society adheres to the Standards for Commercial Support (SCS) of the Accreditation Council for Continuing Medical Education (ACCME) which requires that those individuals in a position to control the content of an educational activity (including planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all relevant* financial relationships (for self and for individual's spouse/partner) with an ACCME-defined commercial interest** from the preceding 12 months.

 

Any individual who refuses to disclose financial relationships is disqualified from participating in HRS educational activities. Employees and Owners of ACCME-defined commercial interests may have no role in the planning or implementation of CME activities without a special exception from the HRS Chief Learning Officer that is granted only in specific circumstances that meet stringent ACCME requirements.


ACCME Definitions:

 *Relevant financial relationships are financial relationships in any amount, which occurred in the twelve-month period preceding the time that the individual was asked to assume a role controlling content of the CME activity, and which relate to the content of the educational activity, causing a conflict of interest. The ACCME considers financial relationships to create conflicts of interest in CME when individuals have both a financial relationship with a commercial interest and the opportunity to affect the content of CME about the products or services of that commercial interest.

 **A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests - unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.


Faculty Disclosures 

Moderators:

  • Hugh Calkins, MD, FHRS, CCDS: Honoraria/Speaking/Consulting Fee: Boston Scientific, Medtronic, Abbott, AtriCure, Bosense Webster, Abbott. Research (Contracted Grants for PIs and Named Investigators only): Boston Scientific
  • Andrea Russo, MD, FHRS: Honoraria/Speaking/Consulting Fee: Biosense Webster, Medtronic Research (Contracted Grants for PIs and Named Investigators only): Boston Scientific, MedyLinx. Royalty Income: Uptodate

Speakers:

  • David DeLurgio, MD, FHRS: Honoraria/Speaking/Consulting Fee: AtriCure, Boston Scientific, Medtronic
  • Andy Kiser, MBA, MD: Honoraria/Speaking/Consulting Fee: AtriCure, Angiodynamics
  • DJ Lakkireddy, MD, FHRS Honoraria/Speaking/Consulting Fee and Research (Contracted Grants for PIs and Named Investigators only): Abbott, Jenssen, AtriCure, SentreHeart, Biotronik, Biosense Webster, Boston Scientific, Medtronic
  • David Wilber, MD, FHRS: Research (Contracted Grants for PIs and Named Investigators only): Boston Scientific, Biosense Webster, Inc. Abbott,  Thermedi
  • Luigi Di Biasi, MD, PhD, FHRS: Honoraria/Speaking/Consulting Fee: Bristol-Myers Squibb, Biosense Webster, Stereotaxis Inc, Medtronic, Biotronik, Abbott, Boston Scientific, Pfizer, Rhythm Management Group Corp. 
  • Suneet Mittal, BA, MD, FHRS: Honoraria/Speaking/Consulting Fee: Sentreheart, Abbott, Boston Scientific, Cardiva Medical, Medtronic, AtriCure

Content Reviewer:
Ralph Verdino, MD, FHRS: Nothing Relevant to Disclose

Staff Disclosures: 

Tonia Jones: Nothing to Disclose
Pam Magnani: Nothing to Disclose

Obse Debela: Nothing to Disclose

 

Content Validation Policy

The Heart Rhythm Society is committed to the provision of Continuing Medical Education (CME) that is balanced, objective, and evidence-based. The Heart Rhythm Society adheres to the Standards for Commercial Support (SCS) of the Accreditation Council for Continuing Medical Education (ACCME) which requires that those individuals in a position to control the content of an educational activity (including planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all relevant financial relationships with an ACCME-defined commercial interest within the 12 months prior to the disclosure.


The Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:

Fair Balance - that content is balanced among various options available for treatment and not biased toward a particular product or manufacturer.

Patient Treatment Recommendations - that patient treatment recommendations contained in the content are evidence-based, are appropriate for the target audience, and that the patient treatment recommendations contribute to overall improvement in patient care.

Scientific Validity - that scientific studies cited in the activity conform to standards accepted by the scientific community.

Learning Objectives - that the educational content supports the learning objectives of the activity, and that the objectives stated for performance-in-practice are actionable and measurable.

Omissions - that no seminal studies, data, or best evidence are missing

Contact Information

CME and CoP Certificates will be awarded and available to download and print following the completion of the course and the course evaluation. Should you have any questions regarding your CME certificate, please contact CME@HRSonline.org.

Summary
Availability: On-Demand
Available Dec 02, 2020 to Dec 01, 2023
Cost: FREE
Credit Offered: 1 CME Credit
1 COP Credit
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 400
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Powered By